公司将以3000万美元收购杜拉司机. Aspire Biopharma to acquire Dura Driver for $30M.

Aspire Biopharma 已签署一份非约束性意向书，收购 Dura Driver Control Systems，一家年收入超过2亿美元的全球汽车供应商。 Aspire Biopharma has signed a non-binding letter of intent to acquire Dura Driver Control Systems, a global automotive supplier with over $200 million in annual revenue. 交易价值3000万美元, 在尽职调查和最终协议的前提下. The deal, valued at $30 million, is subject to due diligence and a definitive agreement. 通过购买该公司的电子驾驶员控制和车辆电气化技术,Aspire计划多样化业务. Aspire plans to diversify its business through the purchase of the company's electronic driver control and vehicle electrification technologies.